Our Leadership Team
Dr Sami K. Jaffar
Managing
Partner
// Practice Lead
Sami has over a decade of consulting experience working with Global Pharma firms and Biotechs defining commercial and medical strategy throughout the product journey.
Sami has previously held leadership positions at Vynamic Consulting, Ernst & Young Consulting (EY-Parthenon) and Navigant Consulting.
A scientist by training, Sami has studied AI & Business Strategy at MIT Sloan School of Management. He holds a D.Phil in Chemistry from the University of Oxford, and M.Sc. in Drug Design from University College London (UCL)
Dr Rafiq Hasan
Commercial Strategy Advisor
// Board Advisor
Rafiq has pursued a highly successful career in the pharma industry globally, including senior positions in ophthalmology with Bayer and Novartis.
As SVP and Global Head of Ophthalmology at Bayer, Rafiq grew the business of Eylea® from launch to over USD 2.5bn in 5 years, including its launch in 5 indications in 3 years.
Rafiq completed his medical training from Guys and St Thomas, University of London, and Executive Education from Harvard Business School.
Dr Kelvin Jackson
Data Science &
AI Advisor
// Board Advisor
Kelvin has been developing Data Science and AI strategies for European financial institutions for over a decade, most recently as Senior Vice President at Houlihan Lokey
A published author in the field of Data Science, Kelvin drives innovative AI approaches across industries, and is at the forefront of AI in financial modelling.
Kelvin holds a D.Phil in Computational Chemistry from the University of Oxford, where he completed his Post-Doctoral training with Prof. Rob Paton.
We need your consent to load the translations
We use a third-party service to translate the website content that may collect data about your activity. Please review the details in the privacy policy and accept the service to view the translations.